Yi Lü

4.4k total citations · 1 hit paper
112 papers, 3.3k citations indexed

About

Yi Lü is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yi Lü has authored 112 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 39 papers in Molecular Biology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yi Lü's work include Bone health and treatments (12 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Bone Metabolism and Diseases (9 papers). Yi Lü is often cited by papers focused on Bone health and treatments (12 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Bone Metabolism and Diseases (9 papers). Yi Lü collaborates with scholars based in China, United States and Japan. Yi Lü's co-authors include Evan T. Keller, Jian Zhang, Zhi Yao, Jinlu Dai, Jian Zhang, Atsushi Mizokami, Guozhi Xiao, Zhejun Cai, Zhong Cai and Qiuyan Chen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

Yi Lü

106 papers receiving 3.2k citations

Hit Papers

Abdominal Aortic Aneurysm: Roles of Inflammatory Cells 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Lü China 32 1.5k 1.2k 684 631 592 112 3.3k
Fan Zhang China 30 1.9k 1.3× 1.1k 0.9× 640 0.9× 741 1.2× 554 0.9× 158 3.8k
Roberto Tamma Italy 34 1.8k 1.2× 971 0.8× 483 0.7× 798 1.3× 624 1.1× 124 3.8k
Anca Maria Cîmpean Romania 24 1.2k 0.8× 1.0k 0.9× 395 0.6× 563 0.9× 388 0.7× 180 2.9k
Qi Mei China 30 1.4k 0.9× 803 0.7× 433 0.6× 473 0.7× 495 0.8× 139 3.3k
Hongmei Zhou China 32 1.3k 0.9× 886 0.7× 417 0.6× 713 1.1× 493 0.8× 175 3.6k
Masayuki Shimoda Japan 32 1.3k 0.9× 1.0k 0.9× 858 1.3× 704 1.1× 414 0.7× 137 3.5k
David Jin United States 23 1.6k 1.1× 1.3k 1.1× 273 0.4× 619 1.0× 480 0.8× 48 3.4k
Claire A. Hart United Kingdom 31 1.3k 0.8× 819 0.7× 462 0.7× 520 0.8× 269 0.5× 61 3.4k
Stefania Mitola Italy 36 2.8k 1.8× 799 0.7× 392 0.6× 729 1.2× 894 1.5× 111 4.9k

Countries citing papers authored by Yi Lü

Since Specialization
Citations

This map shows the geographic impact of Yi Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Lü more than expected).

Fields of papers citing papers by Yi Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Lü. The network helps show where Yi Lü may publish in the future.

Co-authorship network of co-authors of Yi Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Lü. A scholar is included among the top collaborators of Yi Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Lü. Yi Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xia, Qi‐Dong, Jian‐Xuan Sun, Zhipeng Yao, et al.. (2024). The role of TERT C228T and KDM6A alterations and TME in NMIBC treated with BCG. npj Precision Oncology. 8(1). 216–216. 2 indexed citations
2.
Lü, Yi, Tao Qing, Fen Xiong, et al.. (2024). An oncogene regulating chromatin favors response to immunotherapy. OncoImmunology. 13(1). 2303195–2303195. 3 indexed citations
3.
Yan, Defeng, Yi Lü, Jinming Liu, et al.. (2023). Enhanced water transportation on a superhydrophilic serial cycloid-shaped pattern. Nanoscale. 15(27). 11473–11481. 57 indexed citations
4.
Lefterov, Iliya, Nicholas F. Fitz, Yi Lü, & Radosveta Koldamova. (2023). APOEε4 and risk of Alzheimer’s disease – time to move forward. Frontiers in Neuroscience. 17. 1195724–1195724. 7 indexed citations
5.
Wang, Deqiang, Xiaofeng Chen, Yian Du, et al.. (2022). Associations of HER2 Mutation With Immune-Related Features and Immunotherapy Outcomes in Solid Tumors. Frontiers in Immunology. 13. 799988–799988. 13 indexed citations
6.
Ding, Huan, Li Shi, Zhuo Chen, et al.. (2022). Construction and evaluation of a prognostic risk model of tumor metastasis-related genes in patients with non-small cell lung cancer. BMC Medical Genomics. 15(1). 187–187. 3 indexed citations
7.
Yu, Wei, Xiao Zhang, Wei Zhang, et al.. (2021). 19-Hydroxybufalin inhibits non-small cell lung cancer cell proliferation and promotes cell apoptosis via the Wnt/β-catenin pathway. Experimental Hematology and Oncology. 10(1). 48–48. 17 indexed citations
8.
Lü, Yi, Tao Qin, Xiaofeng Chen, et al.. (2021). Glutamine Metabolism Scoring Predicts Prognosis and Therapeutic Resistance in Hepatocellular Carcinoma. Pathology & Oncology Research. 27. 1610075–1610075. 14 indexed citations
9.
Yuan, Zhen, et al.. (2021). The Protective Effect of Metformin on Abdominal Aortic Aneurysm: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology. 12. 721213–721213. 13 indexed citations
10.
Zeng, Yonglian, Zhenya Guo, Zhigao Hu, et al.. (2020). FGD1 exhibits oncogenic properties in hepatocellular carcinoma through regulating cell morphology, autophagy and mitochondrial function. Biomedicine & Pharmacotherapy. 125. 110029–110029. 13 indexed citations
11.
Wang, Yidong, Liangliang Jia, Yao Xie, et al.. (2019). Involvement of macrophage-derived exosomes in abdominal aortic aneurysms development. Atherosclerosis. 289. 64–72. 60 indexed citations
12.
Wei, Jia, Daxing Tang, Jin Yang, et al.. (2019). Irf5 deficiency in myeloid cells prevents necrotizing enterocolitis by inhibiting M1 macrophage polarization. Mucosal Immunology. 12(4). 888–896. 36 indexed citations
13.
Wang, Fuhao, Qiuyan Chen, Jinlu Dai, et al.. (2019). Targeting cathepsin K diminishes prostate cancer establishment and growth in murine bone. Journal of Cancer Research and Clinical Oncology. 145(8). 1999–2012. 30 indexed citations
14.
Tong, Haibo, Chunlin Zou, Jie Meng, et al.. (2018). Prostate cancer tends to metastasize in the bone-mimicking microenvironment via activating NF-kB signaling. Journal of Biomedical Research. 32(5). 343–343. 6 indexed citations
15.
Wang, Lihui, Atsushi Mizokami, Junlin Shi, et al.. (2017). Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling. Chinese Journal of Cancer. 36(1). 35–35. 68 indexed citations
16.
Hong, Defei, Yahui Liu, Yuhua Zhang, et al.. (2016). Laparoscopic and hybrid laparoscopic robotic pancreaticoduodenectomy: a report of 80 cases. 36(8). 893. 1 indexed citations
17.
Xu, Jianjiang, Jiaxu Hong, Xinghuai Sun, et al.. (2015). Combined Lacrimal Passage Probing and Tobramycin/Dexamethasone Ophthalmic Ointment Infiltration. Medicine. 94(36). e1483–e1483. 2 indexed citations
18.
Lindholm, Paul F., et al.. (2010). Role of monocyte‐lineage cells in prostate cancer cell invasion and tissue factor expression. The Prostate. 70(15). 1672–1682. 24 indexed citations
19.
Lü, Yi, Qiuyan Chen, Eva Corey, et al.. (2008). Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone. Clinical & Experimental Metastasis. 26(2). 161–169. 91 indexed citations
20.
Lü, Yi. (2005). Summer Load Characteristic Analysis Based on Body Comfort Index. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026